These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 14018301

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acetohexamide: comparison with other sulfonylurea compounds in the treatment of diabetes mellitus.
    BOSHELL BR, WILENSKY AS, BARRETT JC, ALMON JV.
    Clin Pharmacol Ther; 1962; 3():750-7. PubMed ID: 14014164
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HYPOGLYCEMIC COMA DURING SULFONYLUREA THERAPY.
    BERGMAN H.
    Acta Med Scand; 1965 Mar; 177():287-98. PubMed ID: 14281786
    [No Abstract] [Full Text] [Related]

  • 6. Clinical and experimental findings after five years' treatment of diabetes with sulfonylureas.
    MEHNERT H.
    Diabetes; 1962 Mar; 11(Suppl)():80-4. PubMed ID: 13934500
    [No Abstract] [Full Text] [Related]

  • 7. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
    KLINGER R, DALLECOSTE P.
    Minerva Med; 1964 Jul 14; 55():2237-40. PubMed ID: 14179829
    [No Abstract] [Full Text] [Related]

  • 8. [SIDE-EFFECTS IN THE ORAL TREATMENT OF DIABETES WITH SULFONYLUREAS].
    OSTMAN J, GROENBERG A.
    Nord Med; 1964 Nov 19; 72():1388-95. PubMed ID: 14210083
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. THE ACTION OF SULFONYLUREAS IN PRODUCING HYPOGLYCEMIA.
    WILENSKY AS.
    Ala J Med Sci; 1964 Jan 19; 1():83-91. PubMed ID: 14192740
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. LONG-TERM OBSERVATIONS ON ORAL HYPOGLYCEMIC AGENTS IN DIABETES; THE EFFECT OF CARBUTAMIDE AND TOLBUTAMIDE.
    BERNHARD H.
    Diabetes; 1965 Feb 19; 14():59-70. PubMed ID: 14256053
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [ORAL DIABETES THERAPY].
    HEISIG N.
    Internist (Berl); 1964 Mar 19; 5():140-5. PubMed ID: 14175274
    [No Abstract] [Full Text] [Related]

  • 16. Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.
    Becker ML, Visser LE, Trienekens PH, Hofman A, van Schaik RH, Stricker BH.
    Clin Pharmacol Ther; 2008 Feb 19; 83(2):288-92. PubMed ID: 17597710
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative study with tolbutamide and glibornuride for the diagnosis of latent diabetes mellitus].
    Wieser O, Iglauer E.
    Wien Klin Wochenschr; 1972 Nov 10; 84(45):733-4. PubMed ID: 4634673
    [No Abstract] [Full Text] [Related]

  • 19. Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents.
    Herman JB.
    Isr J Med Sci; 1966 Nov 10; 2(6):733-7. PubMed ID: 5956689
    [No Abstract] [Full Text] [Related]

  • 20. [Excretion of oral antidiabetics of the sulfonylurea-series through choledochus drainage].
    Fürstenberg H, Bussmann JF, Schmidt FH, Stork H, Bauer G.
    Arzneimittelforschung; 1969 Jun 10; 19(6):1016-9. PubMed ID: 5820028
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.